[go: up one dir, main page]

ES420210A1 - Un procedimiento para preparar 4-hidroxi-6-arilpirimidinas. - Google Patents

Un procedimiento para preparar 4-hidroxi-6-arilpirimidinas.

Info

Publication number
ES420210A1
ES420210A1 ES420210A ES420210A ES420210A1 ES 420210 A1 ES420210 A1 ES 420210A1 ES 420210 A ES420210 A ES 420210A ES 420210 A ES420210 A ES 420210A ES 420210 A1 ES420210 A1 ES 420210A1
Authority
ES
Spain
Prior art keywords
carbon atoms
formula
amino
phenyl
furyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES420210A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Corp Belgium
Pfizer Inc
Original Assignee
Pfizer Corp Belgium
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Corp Belgium, Pfizer Inc filed Critical Pfizer Corp Belgium
Publication of ES420210A1 publication Critical patent/ES420210A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/30Halogen atoms or nitro radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/34One oxygen atom
    • C07D239/36One oxygen atom as doubly bound oxygen atom or as unsubstituted hydroxy radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/42One nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/56One oxygen atom and one sulfur atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/62Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/68Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D333/70Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
ES420210A 1970-10-05 1973-11-02 Un procedimiento para preparar 4-hidroxi-6-arilpirimidinas. Expired ES420210A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7821670A 1970-10-05 1970-10-05

Publications (1)

Publication Number Publication Date
ES420210A1 true ES420210A1 (es) 1976-06-01

Family

ID=22142671

Family Applications (4)

Application Number Title Priority Date Filing Date
ES395676A Expired ES395676A1 (es) 1970-10-05 1971-10-04 Un metodo para preparar una 4-amino-6-arilpirimidina.
ES420211A Expired ES420211A1 (es) 1970-10-05 1973-11-02 Un procedimiento para preparar 4-hidroxi-6-arilpirimidinas.
ES420210A Expired ES420210A1 (es) 1970-10-05 1973-11-02 Un procedimiento para preparar 4-hidroxi-6-arilpirimidinas.
ES420209A Expired ES420209A1 (es) 1970-10-05 1973-11-02 Un metodo para preparar 4-amino-6-arilpirimidinas.

Family Applications Before (2)

Application Number Title Priority Date Filing Date
ES395676A Expired ES395676A1 (es) 1970-10-05 1971-10-04 Un metodo para preparar una 4-amino-6-arilpirimidina.
ES420211A Expired ES420211A1 (es) 1970-10-05 1973-11-02 Un procedimiento para preparar 4-hidroxi-6-arilpirimidinas.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES420209A Expired ES420209A1 (es) 1970-10-05 1973-11-02 Un metodo para preparar 4-amino-6-arilpirimidinas.

Country Status (16)

Country Link
US (1) US3707560A (es)
JP (2) JPS5648511B1 (es)
AT (4) AT314540B (es)
AU (1) AU465734B2 (es)
BE (1) BE773484A (es)
CA (1) CA988519A (es)
CH (4) CH554875A (es)
DE (2) DE2165962C2 (es)
DK (1) DK131858C (es)
ES (4) ES395676A1 (es)
FI (1) FI55502C (es)
FR (1) FR2110227B1 (es)
GB (2) GB1373536A (es)
NL (1) NL168511C (es)
SE (2) SE385885B (es)
ZA (1) ZA716615B (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3908012A (en) * 1970-10-05 1975-09-23 Pfizer Arylpyrimidines-inhibitors of platelet aggregation and bronchodilators
US3895112A (en) * 1970-10-05 1975-07-15 Pfizer Arylpyrimidines in the relaxation of smooth muscle
US3859288A (en) * 1970-10-05 1975-01-07 Pfizer Arylpyrimidines - inhibitors of platelet aggregation and bronchodilators
US3835132A (en) * 1972-02-01 1974-09-10 Shell Oil Co Morpholino-piperazinyl pyrimidines
US3950525A (en) * 1973-06-19 1976-04-13 Pfizer Inc. Relaxation of smooth muscle in a mammal
DE2343419A1 (de) * 1973-08-29 1975-03-13 Gruenenthal Chemie Verfahren zur herstellung von pyrimidinderivaten
US4725600A (en) * 1984-07-13 1988-02-16 Fujisawa Pharmaceutical Co., Ltd. Pyrimidine compounds having activity as a cardiotonic anti-hypertensive cerebrovascular vasodilator and anti-platelet aggregation agent
US4935516A (en) * 1988-01-29 1990-06-19 Ube Industries, Ltd. Process for preparing 4-hydroxypyrimidine
JPH0625157B2 (ja) * 1988-01-29 1994-04-06 宇部興産株式会社 4―ヒドロキシピリミジン類の製造方法
DE3825647A1 (de) * 1988-07-28 1990-02-01 Geyer Gmbh & Co Christian Vorrichtung zur befestigung eines elektrischen schaltgeraetes
DE3905364A1 (de) * 1989-02-22 1990-08-23 Hoechst Ag Substituierte pyrimidin-derivate, verfahren zu ihrer herstellung und ihre verwendung als tool
AU777735B2 (en) * 1999-07-15 2004-10-28 Pharmacopeia, Inc. Bradykinin B1 receptor antagonists
ES2290436T3 (es) * 2002-03-15 2008-02-16 Ciba Specialty Chemicals Holding Inc. Uso de 4-aminopiridinas para el tratamiento antimicrobiano de superficies.
MXPA04011472A (es) * 2002-05-22 2005-02-14 Amgen Inc Derivados de amino-piridina, piridina y piridazina para usarse como ligandos del receptor vaniloide para el tratamiento del dolor.
EP1611128A2 (en) * 2003-03-28 2006-01-04 Pharmacia & Upjohn Company LLC Positive allosteric modulators of the nicotinic acetylcholine receptor
WO2006113769A1 (en) * 2005-04-15 2006-10-26 Amgen Inc. Vanilloid receptor ligands and their use in treatments
JP2009164373A (ja) * 2008-01-08 2009-07-23 Toshiba Corp 半導体装置
NZ601547A (en) * 2010-01-25 2014-04-30 Chdi Foundation Inc Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
PH12017502049A1 (en) 2011-08-30 2018-08-29 Chdi Foundation Inc Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
CN103827095A (zh) 2011-08-30 2014-05-28 Chdi基金会股份有限公司 犬尿氨酸-3-单加氧酶抑制剂、其药物组合物及其使用方法
PE20170770A1 (es) 2014-07-17 2017-07-04 Chdi Foundation Inc Metodos y composiciones para tratar trastornos relacionados con vih

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3047462A (en) * 1959-03-06 1962-07-31 Lab Jacques Logeais Soc D Expl Quinazolone anti-inflammatory composition

Also Published As

Publication number Publication date
DE2165962C2 (de) 1982-05-13
CH554875A (fr) 1974-10-15
DE2165962A1 (de) 1972-08-31
FR2110227B1 (es) 1975-02-07
AU465734B2 (en) 1975-10-09
DK131858B (da) 1975-09-15
ES395676A1 (es) 1974-10-16
JPS5636468A (en) 1981-04-09
AT314540B (de) 1974-04-10
ES420209A1 (es) 1976-06-01
FR2110227A1 (es) 1972-06-02
DK131858C (da) 1976-02-16
NL168511B (nl) 1981-11-16
CH554876A (fr) 1974-10-15
GB1373535A (en) 1974-11-13
SE390304B (sv) 1976-12-13
BE773484A (fr) 1972-04-05
ES420211A1 (es) 1976-03-16
ZA716615B (en) 1972-06-28
AT315856B (de) 1974-05-15
SE7410488L (es) 1974-08-16
GB1373536A (en) 1974-11-13
AT317229B (de) 1974-08-26
CA988519A (en) 1976-05-04
DE2149249A1 (de) 1972-04-13
JPS578107B2 (es) 1982-02-15
AT316563B (de) 1974-06-15
DE2149249C3 (de) 1975-07-03
CH542218A (fr) 1973-11-15
DE2149249B2 (de) 1974-11-07
NL168511C (nl) 1982-04-16
SE385885B (sv) 1976-07-26
JPS5648511B1 (es) 1981-11-16
FI55502C (fi) 1979-08-10
FI55502B (fi) 1979-04-30
US3707560A (en) 1972-12-26
NL7113670A (es) 1972-04-07
CH554346A (fr) 1974-09-30
AU3425971A (en) 1973-04-12

Similar Documents

Publication Publication Date Title
ES420210A1 (es) Un procedimiento para preparar 4-hidroxi-6-arilpirimidinas.
ES394369A1 (es) Procedimiento para la preparacion de derivados de la isoin-dolina.
ES425900A1 (es) Procedimiento para la preparacion de nuevos compuestos de isoflavona.
ES462422A1 (es) Procedimiento para la preparacion de compuestos derivados den-alquil-sulfo-noxi-acetil-anilinas.
ES440029A1 (es) Un procedimiento para preparar nuevos derivados de 2-ami- noindano.
ES395766A1 (es) Procedimiento para la obtencion de derivados de la hidan- toina.
ES474468A1 (es) Procedimiento para la preparacion de piperacina -1-(n-aril- n'-cianocarboximidamidas 4-substituidas
ES410313A2 (es) Procedimiento para lapreparacion de 6,7-dimetoxi-quinazoli-nonas.
ES451466A1 (es) Procedimiento para la preparacion de nuevos derivados de 5- tiazol-metanoamina.
ES412380A1 (es) Un procedimiento para la preparacion de salicilanilidas.
ES444036A1 (es) Procedimiento de preparacion de la (tienil-2)-2-etilamina y sus derivados.
ES458021A1 (es) Procedimiento para la obtencion de derivados de acido pros- tanoico.
ES430416A1 (es) Procedimiento para preparar derivados de prostaglandina.
ES391118A1 (es) Un procedimiento para la preparacion de un nuevo derivado de acido fluoronico.
ES445922A1 (es) Procedimiento para preparar derivados de benzofuranona.
ES449429A1 (es) Procedimiento para preparar derivados de benzocicloheptatio-feno.
ES437041A1 (es) Un procedimiento para preparar derivados de 1-ftalazona.
ES262405A1 (es) Un procedimiento para la preparaciën de derivados hidrazinicos
ES457895A1 (es) Metodo para preparar derivados de tirosina.
ES322107A1 (es) Procedimiento para la obtenciën de derivados de 6-epi-6-desoxitetraciclinas
ES398633A1 (es) Procedimiento para la preparacion de nuevos derivados de 3-(2-fenilisopropil) urea.
ES458164A1 (es) Procedimiento para preparar derivados de imidazolidina sus- tituidos.
ES414054A1 (es) Procedimiento para preparar derivados del furano.
ES462441A1 (es) Un procedimiento para la preparacion de imidazoles.
ES392665A1 (es) Un procedimiento para preparar derivados de benzodiazepina-1-sustituidos y sales de los mismos.